Bullous Pemphigoid: Exploring New Frontiers
Time: 3:30 pm
day: Conference Day Two
Details:
- Describe the heterogenous clinical presentations, disease burden, and diagnosis of bullous pemphigoid (BP)
- Highlight current understanding of BP pathophysiology and the critical role of autoimmunity and type 2 inflammation in both clinical signs and itch
- Discuss unmet needs from a clinical management perspective and how targeted therapies may address them
